Search for: "Pfizer Pharmaceutic, Inc." Results 261 - 280 of 667
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 May 2022, 2:26 am by Matrix Legal Support Service
The Appellants are both pharmaceutical companies fined by the CMA and both appealed to the Competition Appeal Tribunal (CAT) challenging the CMA’s decision. [read post]
31 Aug 2010, 10:01 pm by Kelly
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
17 Feb 2009, 6:53 am
  The case involves a group of investors (collectively, the “Plaintiffs”) alleging that Pharmacia, Inc. and its acquirer, Pfizer, Inc., (collectively, the “Defendants”) violated §§ 10(b) and 20(a) of the Securities Exchange Act of 1934 by making, with scienter, materially false statements about a clinical study of Celebrex. [read post]
1 Jun 2011, 7:47 am
Pfizer, Inc., appears at 2011-1 Trade Cases ¶77,455. [read post]
17 May 2007, 9:09 am
Pfizer, Inc., 2004 WL 2191804, at *6 (S.D. [read post]
23 Nov 2010, 2:00 pm by admin
A $2.3 billion settlement with Pfizer Inc. marked the largest health care fraud settlement in history. [read post]
19 Oct 2006, 7:29 pm
The global pharmaceutical market is forecast to grow to $842 billion in 2010. [read post]
8 Mar 2012, 5:37 pm by Mark Zamora
The agency released its safety analysis ahead of a public meeting next week where outside experts will discuss the drugs' safety.Pfizer halted studies of its experimental injection tanezumab in patients with osteoarthritis, low back pain and diabetic nerve pain.On Monday, Pfizer Inc., Johnson & Johnson and Regeneron Pharmaceuticals will make their case to continue studies of the drugs, with new safety precautions to protect patients. [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]
8 Mar 2012, 3:34 am by Dan Hargrove
In April 2011, Johnson & Johnson agreed to pay $70 million to resolve violations, and The Wall Street Journal reported in November 2011 that Pfizer Inc. will pay more than $60 million when its settlement gets finalized. [read post]